Brief: Oncolytics Biotech Announces Publication Of Preclinical, Patient Data Demonstrating Pelareorep's Stimulation Of Natural Killer Cell Anti-Cancer Activity
17/03/2022 11:07
March 17 (Reuters) - Oncolytics Biotech Inc ONC.TO :
* ONCOLYTICS BIOTECH® ANNOUNCES PUBLICATION OF PRECLINICAL
AND
PATIENT DATA DEMONSTRATING PELAREOREP'S STIMULATION OF NATURAL
KILLER CELL ANTI-CANCER ACTIVITY
Source text for Eikon: ID:nCNWPRmtta
Further company coverage: ONC.TO
Recent news on Oncolytics Biotech
See all newsBrief: Oncolytics Biotech Files For Mixed Shelf Offering Of Up To $150 Million
Brief: Oncolytics Biotech® Announces Voluntary Delisting From The Toronto Stock Exchange
Advisory: Alert on global oncology breakthroughs tagged to multiple pharma firms withdrawn
Brief: Oncolytics Biotech® Appoints Former Ambrx Executive As Chief Business Officer
Brief: Oncolytics Biotech Appoints Former Ambrx Executive As Chief Business Officer